Get started

INO

Inovio is turning. INO? Wave A or something else. It is unclear what is forming in this picture exactly, but you can see the momentum shift in the candlesticks. Volatility and parabolism have both turned negative to add fuel to the fire. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
NASDAQ:INOShort
by Rykin_Capital
INO What You're Thinking...INO finally broke back above the 786 fib line. Before the last bout of selling, you'll see this level was an area of support for the former penny stock. Now, thanks to some added excitement from delta news (the variant not the airline), INO shares are popping. They also jumped back above the 786 fib. Now the question is, will it rest the 618 fib like it tried to a few weeks ago? "Inovio Pharmaceuticals Inc. (NASDAQ: INO) has steadily climbed for the better part of the last 3 months thanks to recent pipeline progress. In June, the company had expanded its partnership with Advaccine Biopharmaceuticals Suzhou to conduct a Phase 3 segment of a trial called INNOVATE. The goal is to evaluate the safety and efficacy of the company’s INO-4800 in COVID patients. The treatment was already shown to be well tolerated and immunogenic in tested age groups in a Phase 2 study. This month Inovio announced that it and Advaccine received a regulatory allowance for 2 heterologous prime-boost clinical trials in China using INO-4800. “VID-19. If approved, we believe INO-4800 will be well-positioned to serve the vaccine needs of the global community as both a primary and a booster vaccine due to its tolerability, balanced cross-reactive immune responses, and strong thermostability profile that does not require cold or ultra-cold-chain transport,” said Dr. J. Joseph Kim, President, and CEO of INOVIO." Quote Source & Read more on INO: Former Penny Stocks To Watch After Merck’s ( MRK ) Latest FDA Win
NASDAQ:INO
by PennyStocks101
1
$TELL $INO $ELSE $EBON $ACB $AMRNHello community, Hope you had good weekend and are ready for this week . Markets are in funky stage at this point and its definitely hard to predict what will happen . Over all conditions are I think sideways but you never know what will happen , There is old saying is SELL IN MAY AND GO AWAY It could be best approach with this chop market and patience might be the best play for next coming months . I pulled some plays from my watch list because I think we can make some profits on it , Most of the information's you will find on each chart. Make sure you apply strategy of your own with any trades you take and don't follow anyone . Make sure you take your profits and the most important of all PROTECT YOUR CAPITAL . www.tradingview.com www.tradingview.com www.tradingview.com www.tradingview.com www.tradingview.com Share your opinions . Hit that like icon if you like any of these . Wish you best with your plays ! See you next time
T
by PTO
6
INO Technical Analysis 🧙Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:INOLong
by unfair_advantage
The Week Ahead: MJ, SRNE, INO, NKLA, XOP, ICLN, IWM PremiumLooking for the juice? Here's where it's at ... . Options Highly Liquid Single Name >$10/Share With Earnings in the Rear View, Sorted By 30-Day with a >50% Cut-Off: CRON (43/236) (Cannabis) AMC (21/218) (Theatres) TLRY (40/185) (Cannabis) SRNE (5/165) (Biotech) INO (4/145) (Biotech) ACB (11/127) (Cannabis) NKLA (12/125) (EV) CGC (23/99) (Cannabis) NCLH (4/99) (Cruise Lines) NIO (34/97) (ADR; EV) M (5/80) (Retail) IQ (13/75) (ADR; Internet) RCL (2/72) (Cruise Lines) DKNG (5/69) (Online Gambling) CLDR (6/64) (Software) JD (28/61) (ADR; Internet Retail) DDOG (19/61) (Software) GPS (10/54) (Apparel) AEO (1/52) (Apparel) Options Highly Liquid Exchange-Traded Funds, Sorted By 30-Day, With a >35% Cut-Off: MJ (47/80) (Cannabis) XOP (6/57) (Oil and Gas) ICLN (10/54) (Clean Energy) LIT (40/52) (Battery Tech) JETS (1/46) (Airlines) EWU (3/46) (United Kingdom) XBI (20/44) (Biotech) EWZ (3/43) (Brazil) XLE (6/41) (Energy) GDX (3/39) (Gold Miners) KRE (6/38) (Regional Banks) SLV (8/38) (Silver) XLK (7/36) (Technology) Broad Market, Sorted by 30-Day: IWM (7/31) QQQ (10/31) SPY (3/20) DIA (0/20) EFA (2/15) The Pictured Trade: Depicted here is an MJ July 16th (124 DTE) 17 short put, which was paying 1.11 at the mid price as of Friday close, 6.99% ROC at max as a function of notional risk (20.6% annualized). This is quite a bit more long-dated than I like to go generally, so I'll probably wait for a May monthly to open up (probably next week after the March monthly drops off) before considering doing anything. Similarly, neither ICLN, LIT, nor JETS have May monthlies yet and April will have a gotten a bit short in duration (currently 33 DTE) for those like me who prefer to work with a 45 day or less wheel house.
AMEX:MJ
by NaughtyPines
WATCHLIST - WEEK OF 2/1 - 2/5QQQ broke the 20 day MA on Friday. Would love to see that level reclaimed for more upside in the market. Here are some levels I see for this week (note, these are intraday levels - not swing levels). Of course, this is just my opinion and I am not liable for your trading decisions. INO calls over 13.1 or 13.7 CRWD calls over 218.25 BYND puts under 177 JMIA puts under 54.3 If the market rallys this week then calls over 60 will work too PYPL puts under 232.6
NASDAQ:QQQ
by algrowithm
4